Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01402050 · ClinicalTrials.gov registry record · NA

Foley Catheter Versus Cervidil for Induction of Labor at Term

A NA study of Labor Induction, sponsored by Pediatrix.

Completed
Registry status
NA
Development phase
376
Enrollment target
2
Study locations

NCT01402050 is a NA study of Labor Induction that has completed, run by Pediatrix. The registered enrollment target is 376 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01402050, a NA study of Labor Induction, has completed, sponsored by Pediatrix.

COMPLETED
Registry status
NA
Development phase
376 participants
Enrollment target
2
Study locations

Study Summary

OBJECTIVE: To assess the efficacy of transcervical Foley catheter compared to controlled release prostaglandin (Cervidil™) for cervical ripening in term and near term women presenting for labor induction. HYPOTHESIS: In term and near term women presenting for labor induction, transcervical Foley catheter will decrease the mean time from induction to delivery by six hours compared to controlled release prostaglandin (Cervidil™).

Conditions Studied

Interventions

  • DRUG CERVIDIL (Dinoprostone)
  • DEVICE FOLEY BALLOON

Study Locations (2)

Arizona

  • Banner Desert Medical Center - Mesa
  • Banner Good Samaritan Medical Center - Phoenix

Trial Details

FieldValue
Enrollment Target 376 participants
Start Date 2010-06
Est. Completion 2015-02
Phase NA

Sponsor

Pediatrix

28 total trials

What the Registry Record Tells You About NCT01402050

The ClinicalTrials.gov registry entry for NCT01402050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Labor Induction appearing as the primary indexed condition, and to 2 interventions - of which CERVIDIL (Dinoprostone) is the first listed.

NCT01402050 reports 2 study locations spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT01402050 about?

NCT01402050 is a clinical study titled "Foley Catheter Versus Cervidil for Induction of Labor at Term". OBJECTIVE: To assess the efficacy of transcervical Foley catheter compared to controlled release prostaglandin (Cervidil™) for cervical ripening in term and near term women presenting for labor induction. HYPOTHESIS: In term and near term women presenting for labor induction, transcervical Foley ca...

What is the current status of trial NCT01402050?

This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2010-06. Estimated completion is 2015-02.

What conditions does trial NCT01402050 study?

This clinical trial studies the following conditions: Labor Induction.

What interventions are being tested in trial NCT01402050?

The interventions under investigation include: CERVIDIL (Dinoprostone) (DRUG), FOLEY BALLOON (DEVICE).

Who is sponsoring clinical trial NCT01402050?

This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01402050 being conducted?

This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor Induction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.